Related Experiment Videos
Efficient generation and characterization of tumor cell subclones with different adhesion pathways involved in cell
P Lefterova1, R Negrin, A Neubauer
1Abteilung Innere Medizin, Freie Universität Berlin, Germany.
Background:
Specific tumor cell recognition is required for optimal tumor directed therapy. Lymphokine activated killer (LAK) cells are able to recognize tumor targets specifically because LAK cells can distinguish between normal and tumor cells. This study was aimed at analyzing receptor molecules on tumor cells and their counter-receptor molecules on LAK cells. Cell lines which differ in the pathway by which LAK cell lysis is mediated are important for an analysis of receptor molecules.
Methods:
We adapted a novel method for efficient production of K562 clones in order to analyze the mechanisms by which target and effector receptor molecules mediate different LAK cell interactions. K562 cells were exposed to ethyl methanesulfonate (EMS) for mutagenization and addition of two rounds of irradiated LAK cells. Prior data demonstrated that irradiation does not effect cytolysis. Surviving cells were plated in methylcellulose and single colonies were obtained after ten days. Cells were washed, resuspended in medium, expanded and tested as targets in a 51Cr-release assay.
Results:
With this procedure a variety of clones could be generated easily and time-savingly. All twelve clones expressed the bcr/abl transcript, as determined by PCR, and were sensitive to LAK cell lysis. However, cell blockage studies revealed that K562 clones were generated with LAK cell recognition differing from parental K562. Antibody blockage showed that lysis of clone 5 (LEF 5) is partially mediated via the LFA-1/ICAM-1 pathway. ICAM-1 expression of this clone was similar to expression on K562, as determined by flow cytometry.
Conclusions:
These clones are of great value for studying the receptor molecules involved in LAK--tumor cell interactions.
Insights
Researchers developed a new method to create K562 cell clones for studying Lymphokine-Activated Killer (LAK) cell interactions. These clones reveal differences in LAK cell recognition pathways, aiding the understanding of LAK-tumor cell interactions.
Area of Science:
- Immunology
- Cell Biology
- Cancer Therapy
Background:
- Optimal tumor-directed therapy relies on specific tumor cell recognition by effector cells.
- Lymphokine-Activated Killer (LAK) cells possess the ability to specifically recognize and lyse tumor cells, distinguishing them from normal cells.
- Understanding the receptor-ligand interactions between LAK cells and tumor cells is crucial for advancing immunotherapy.
Purpose of the Study:
- To develop an efficient method for generating K562 cell clones with distinct LAK cell interaction pathways.
- To analyze the receptor-ligand mechanisms involved in LAK cell-mediated lysis of tumor cells.
- To identify specific molecular pathways contributing to LAK cell recognition of tumor targets.
Main Methods:
- A novel method involving ethyl methanesulfonate (EMS) mutagenesis and irradiated LAK cell selection was employed to generate K562 clones.
- Surviving K562 cells were isolated as single colonies, expanded, and tested for LAK cell-mediated cytotoxicity using a 51Cr-release assay.
- Polymerase Chain Reaction (PCR) was used to confirm the bcr/abl transcript in generated clones, and flow cytometry assessed ICAM-1 expression.
Main Results:
- A facile and time-efficient method yielded multiple K562 clones, all expressing the bcr/abl transcript and sensitive to LAK cell lysis.
- Cell blockage studies indicated that some K562 clones exhibited altered LAK cell recognition compared to the parental K562 cell line.
- Antibody-mediated blocking experiments demonstrated that lysis of clone 5 (LEF 5) is partly mediated through the LFA-1/ICAM-1 pathway, with similar ICAM-1 expression to parental cells.
Conclusions:
- The generated K562 clones provide a valuable tool for dissecting the molecular basis of LAK cell-tumor cell interactions.
- These clones facilitate the study of specific receptor-ligand pairs involved in immune recognition and lysis.
- Further research using these clones can elucidate mechanisms of LAK cell targeting and inform the development of novel cancer therapies.